February 21, 2025

Novel Menin Inhibitors Show Safety and Activity in Several Clinical Trials

The recently approved menin inhibitor revumenib is poised to improve the treatment of acute leukemia, specifically for disease with a KMT2A rearrangement. Promising results for other novel menin inhib...

The ASCO Post

February 21, 2025

Study Links Stress to Immune Changes in Breast Cancer

New research shows chronic stressors like perceived stress, inadequate social support, racial discrimination, and neighborhood deprivation are associated with deleterious changes to systemic and tumor immunity in breast cancer patients, with more pronounced effects in Black women.

Conexiant

February 21, 2025

Environmental vs. Genetic Risk in Aging and Mortality

Researchers quantify the exposome's greater impact on aging and mortality risk compared with genetic predisposition, identifying 25 key environmental risk factors.

Conexiant

February 21, 2025

Jennifer A. Woyach, MD, Named The Ohio State’s Director of Hematology

Jennifer A. Woyach, MD, a hematology cancer expert and researcher who has been with The Ohio State for more than 12 years, has been named Director of the Division of Hematology at The Ohio State Unive...

The ASCO Post

February 21, 2025

AAN: Limited Benefits Found for Epidural Steroid Injections

New systematic review from the American Academy of Neurology finds epidural steroid injections offer modest short-term benefits but limited long-term efficacy for treating spinal pain conditions, with varying results across different applications.

Conexiant

February 21, 2025

FDA Approves First Companion Diagnostic to Identify Patients With Metastatic Breast Cancer Eligible for T-DXd

The FDA has approved a label expansion for the PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody to identify patients with HR-positive, HER2-ultralow metastatic breast cancer who may be e...

The ASCO Post

February 21, 2025

Former UNMC Cancer Center Director, Kenneth H. Cowan, MD, PhD, Dies at 77

Kenneth H. Cowan, MD, PhD, served for 24 years as Director of the National Cancer Institute (NCI)-designated cancer center at the University of Nebraska Medical Center (UNMC), now called the Nebraska ...

The ASCO Post

February 21, 2025

Lung-MAP 3.0: Simplifying the Process to Meet Patients’ Needs

The Lung Cancer Master Protocol (Lung-MAP) is an innovative clinical trial designed to efficiently address the unmet needs of patients with advanced non–small cell lung cancer (NSCLC) following front-...

The ASCO Post

February 21, 2025

Cardiometabolic Shifts May Predict Dementia, Study Shows

An accelerated decline in BMI and waist circumference, along with fluctuating HDL levels, may signal early cognitive impairments up to a decade before dementia diagnosis, study finds.

Conexiant